gvtcx

Blood Component Therapies

MINISTRY OF DEFENCE Published 28 Sept 2023 Contracts Finder

key details

Value£164,050
Statuscomplete
Category (CPV) 73000000
Deadline31 Aug 2023
Contract start1 Sept 2023
Contract end31 Aug 2024
Proceduredirect
SME suitableNo
OCIDocds-b5fd17-e44d41ac-ec6d-4328-9740-0c4d50e3862c

Award

SupplierValueDateStatus
Robert Gordon University £164,050 27 Sept 2023 active

description

The Institution will provide the required laboratory facilities and technical support in order for the Principal Investigator to conduct research in order to answer the following objectives:

a.Evaluate clot structure and stability in clots formed from whole blood vs. red blood cell, plasma and platelet component therapy
b.How do additive and storage solutions used to stabilise red blood cell and platelet component therapies alter clot structure and stability?
c.How does cold or warm storage of blood products alter clot structure and stability

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
28 Sept 2023 Award (award) · c2e6a7ca-81e7-4339-97e7-c0ae5908c14d-684420

more from MINISTRY OF DEFENCE

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.